Cardiovascular diseases are the most prominent circulation disorders around the world. Biomarkers are characteristic biological properties that can be objectively measured as an indicator to evaluate a variety of health or disease characteristics. Cardiac biomarkers are a valuable tool for assessing the pathogenesis and diagnosis of cardiovascular diseases. In this review, we will focus on the major biomarkers used in recent clinical research for the diagnosis of cardiovascular diseases, which include mean platelet volume, hyperhomocysteinemia, serum magnesium, microalbuminuria, and prolongation of QT interval and dispersion. We also highlight the key findings of clinical case report based studies presented in this issue of JCDR
Cardiovascular diseases are the main causes of mortality and morbidity in Brazil. Their primary and ...
Biomarkers are essential tools in the practice of cardiology. They assist with diagnosis, prognosis,...
Apart from the use of cardiac biomarker for diagnosing and monitoring Acute ischemic disease, an acu...
Cardiovascular diseases (CVDs) are a major healthcare burden on the population worldwide. Early dete...
BACKGROUND: The investigation of novel circulating serum and plasma biomarkers in patients with card...
According to the Merriam-Webster Online Dictio-nary, a biomarker is ‘a distinctive biological or bio...
BACKGROUND: The investigation of novel circulating serum and plasma biomarkers in patients with card...
Cardiovascular diseases (CVD), a group of diseases that affect the heart and blood vessels have pose...
Copyright © 2015 Ravi Kant Upadhyay.This is an open access article distributed under the Creative Co...
Cardiovascular disease (CVD) remains a global health concern of paramount significance, claiming mil...
Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical de...
In the last two decades, there has been a significant increase in interest in cardiovascular biomark...
Cardiovascular diseases are the leading causes of mortality worldwide. Among them, hypertension and ...
Cardiovascular disease is the most common cause of death worldwide. Advances in biomarker research o...
Background : Cardiovascular disease is one of the major causes of death worldwide. Assessing the ris...
Cardiovascular diseases are the main causes of mortality and morbidity in Brazil. Their primary and ...
Biomarkers are essential tools in the practice of cardiology. They assist with diagnosis, prognosis,...
Apart from the use of cardiac biomarker for diagnosing and monitoring Acute ischemic disease, an acu...
Cardiovascular diseases (CVDs) are a major healthcare burden on the population worldwide. Early dete...
BACKGROUND: The investigation of novel circulating serum and plasma biomarkers in patients with card...
According to the Merriam-Webster Online Dictio-nary, a biomarker is ‘a distinctive biological or bio...
BACKGROUND: The investigation of novel circulating serum and plasma biomarkers in patients with card...
Cardiovascular diseases (CVD), a group of diseases that affect the heart and blood vessels have pose...
Copyright © 2015 Ravi Kant Upadhyay.This is an open access article distributed under the Creative Co...
Cardiovascular disease (CVD) remains a global health concern of paramount significance, claiming mil...
Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical de...
In the last two decades, there has been a significant increase in interest in cardiovascular biomark...
Cardiovascular diseases are the leading causes of mortality worldwide. Among them, hypertension and ...
Cardiovascular disease is the most common cause of death worldwide. Advances in biomarker research o...
Background : Cardiovascular disease is one of the major causes of death worldwide. Assessing the ris...
Cardiovascular diseases are the main causes of mortality and morbidity in Brazil. Their primary and ...
Biomarkers are essential tools in the practice of cardiology. They assist with diagnosis, prognosis,...
Apart from the use of cardiac biomarker for diagnosing and monitoring Acute ischemic disease, an acu...